Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation
By: Delia Dima, Adrian P. Trifa, Mariana Paţiu, Cristian S. Vesa, Ioana C. Frinc, Ljubomir Petrov and Andrei Cucuianu
Open Access
|Aug 2013Language: English
Page range: 29 - 37
Published on: Aug 8, 2013
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2013 Delia Dima, Adrian P. Trifa, Mariana Paţiu, Cristian S. Vesa, Ioana C. Frinc, Ljubomir Petrov, Andrei Cucuianu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.